BSS-CHIR: Non-interventional Study Evaluating the Management of Pain Using a Technique Developed and Commonly Used by the Center, in Patients Who Underwent Arthroscopic Surgery of the Shoulder in the Outpatient Setting.

Sponsor
University Hospital, Limoges (Other)
Overall Status
Completed
CT.gov ID
NCT04189731
Collaborator
Clinique chénieux (Other)
95
1
10.7
8.9

Study Details

Study Description

Brief Summary

Shoulder surgery is performed usually under interscalene block considered as a gold standard. This anesthesia is well suited for hospitalized patients but not for outpatients. The Orthopedic Surgery Department of Clinique Chénieux has been operating patients requiring arthroscopic shoulder surgery with a short interscalene block relayed by a long suprascapular block. The main objective is to evaluate the effectiveness of this method by measuring the average pain over 3 days after the operation.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The surgery of the shoulder is usually performed under interscalene block (ISB), considered as a gold standard. This anesthesia is well suited for hospitalized patients but not for outpatients. Indeed, the ISB entails, in addition to a sensory block, a motor block often useless and important since it extends beyond the shoulder to the entire upper limb. It can also be a source of anxiety and cause the risk of compression in the limb operated because of the extended sensorimotor block. It is also responsible for a painful bounce almost constant with sometimes the very rapid installation of intense pain when the effect of the sensory block disappears. This pain can be difficult to relieve despite frequent use of opioids.

    The Orthopedic and Traumatologic Surgery Department of the Clinique Chénieux has been operating patients requiring arthroscopic surgery of the shoulder according to the following technique. It involves the establishment of a short ISB (between 2h and 4h) relayed by a supra-scapular block (SSB) long (72h) through the placement of a perineural catheter thus allowing a continuous diffusion of Naropein® by an elastomeric pump. The same day or the day after the operation, the patients return to their home and are followed by nurses.

    The objective of this technique is to better manage postoperative pain, thus allowing the management of patients in outpatient surgery. A prospective non-interventional study will make it possible, in a context of common practice, to obtain data on the management of pain in operated patients and then to consider a generalization of this practice to other centers.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    95 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    Non-interventional Study Evaluating the Management of Pain Using a Technique Developed and Commonly Used by the Center, in Patients Who Underwent Arthroscopic Surgery of the Shoulder in the Outpatient Setting.
    Actual Study Start Date :
    Nov 5, 2020
    Actual Primary Completion Date :
    Sep 27, 2021
    Actual Study Completion Date :
    Sep 27, 2021

    Arms and Interventions

    Arm Intervention/Treatment
    supra-scapular block

    Patient will have a short ISB (between 2h and 4h) relayed by a supra-scapular block (SSB) long (72h) through the placement of a perineural catheter thus allowing a continuous diffusion of Naropein® by an elastomeric pump

    Outcome Measures

    Primary Outcome Measures

    1. Average of pain [Day1]

      Score of average pain at D1, D2 and D3 by a numeric pain scale (NPS) <4/10

    2. Average of pain [Day2]

      core of average pain at D2 by a numeric pain scale (NPS) <4/10

    3. Average of pain [Day 3]

      core of average pain at D3 by a numeric pain scale (NPS) <4/10

    Secondary Outcome Measures

    1. Number of readmissions [Day 7]

      Number of readmissions the first week after the operation

    2. Number of painful peaks [Day 0]

      Number of painful peaks on awakening and leaving the block on the day of the operation

    3. Analgesics consummation [Day 1, Day 2, Day 3, Day 4 and Day 7]

      Amount and types of analgesics consumed / consumed non-opioid during the operation and the first week after the operation

    4. Score of Pain [Day 4, Day 7, Day 15 and Day 30]

      Score of minimum, maximum, average pain the month before the operation and by a numeric pain scale (NPS). Scale from 0 to 10.

    5. Satisfied patient rate [Day 30]

      Satisfied patient rate determined by using a satisfaction questionnaire with 4 responses: very satisfied, somewhat satisfied, somewhat dissatisfied and very dissatisfied

    6. Number of postoperative complications [Month 3]

      Number of postoperative complications at 3 month

    7. Cartilaginous Toxicology [Month 6 and Month 12]

      Cartilaginous Toxicology at 6 months and 12 months determined by radiograph of the shoulder of face in 3 rotations

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 70 Years
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • Men, women between 18 and 70 years

    • Patient in need of acromioplasty or rotator cuff surgery (ruptured cuff or calcification of the cuff) or reinsertion of the glenoid bead (Bankart intervention)

    • Patient with an American Society of Anesthesiologists score (ASA) of 1 or 2

    Exclusion Criteria:
    • Patient needing shoulder surgery for other indications and open surgery

    • Patient with cognitive impairment or dementia symptoms

    • Patient with a BMI ≥ 35 without systemic morbidity requiring hospitalization

    • Contraindication to the drugs used in the study (hypersensitivity to ropivacaine or other amide-bonded local anesthetics)

    • Pregnant or lactating patient

    • Patient with severe hepatic impairment

    • Class III antiarrhythmic patient

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Clinique Chénieux Limoges France

    Sponsors and Collaborators

    • University Hospital, Limoges
    • Clinique chénieux

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Limoges
    ClinicalTrials.gov Identifier:
    NCT04189731
    Other Study ID Numbers:
    • 87RI19_0031 (BSS-CHIR)
    First Posted:
    Dec 6, 2019
    Last Update Posted:
    Jan 24, 2022
    Last Verified:
    Jan 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Hospital, Limoges
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 24, 2022